NASDAQ:ASPI • US00218A1051
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ASP ISOTOPES INC (ASPI).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-04 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-11-24 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-21 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-04 | Canaccord Genuity | Initiate | Buy |
| 2024-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-05 | HC Wainwright & Co. | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 433K | 4.144M 857.09% | 8.633M 108.32% | 43.459M 403.41% | 98.429M 126.49% | 384.62M 290.76% | 523.47M 36.10% | 628.98M 20.16% | ||
| EBITDA YoY % growth | N/A | -16.005M | -25.882M -61.72% | -33.931M -31.10% | -28.074M 17.26% | -5.389M 80.81% | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.1M -95.40% | -16.042M -214.55% | -26.354M -64.28% | -46.587M -76.78% | -24.664M 47.06% | 3.298M 113.37% | 116.72M 3,439.11% | 261.53M 124.07% | 285.23M 9.06% | |
| Operating Margin | N/A | -3,704.85% | -635.92% | -539.64% | -56.75% | 3.35% | 30.35% | 49.96% | 45.35% | |
| EPS YoY % growth | N/A | N/A | N/A -18.75% | -1.20 -107.02% | -0.51 57.34% | -0.50 3.31% | 0.65 231.51% | 2.03 210.94% | 1.65 -18.84% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 0.61% | -0.12 3.67% | -0.12 88.12% | -0.11 19.86% | -0.10 26.32% | -0.20 -72.06% | -0.19 -58.33% | -0.17 -50.00% | -0.14 -44.65% | 0.00 100.00% | 0.07 136.84% | 0.20 221.21% |
| Revenue Q2Q % growth | 2.579M 116.00% | 6.66M 504.57% | 8.801M 634.43% | 11.485M 134.87% | 15.228M 490.46% | 18.564M 178.74% | 21.522M 144.54% | 26.112M 127.36% | 30.753M 101.95% | 58.956M 217.58% | 76.806M 256.87% | 105.77M 305.06% |
| EBITDA Q2Q % growth | -10.632M -48.15% | -9.068M -16.21% | -8.359M 25.96% | -7.093M 49.30% | -4.364M 58.95% | -13.677M -50.82% | -11.983M -43.36% | -9.837M -38.68% | -8.265M -89.39% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -13.659M -78.60% | -12.324M -54.97% | -13.718M -14.62% | -13.137M 12.23% | -11.093M 18.79% | -23.223M -88.45% | -22.269M -62.33% | -20.862M -58.80% | -18.723M -68.79% | N/A | N/A | N/A |
All data in USD
9 analysts have analysed ASPI and the average price target is 13.26 USD. This implies a price increase of 128.23% is expected in the next year compared to the current price of 5.81.
ASP ISOTOPES INC (ASPI) will report earnings on 2026-03-30.
The consensus EPS estimate for the next earnings of ASP ISOTOPES INC (ASPI) is -0.13 USD and the consensus revenue estimate is 2.58M USD.
The expected long term growth rate for ASP ISOTOPES INC (ASPI) is 186.58%.